CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Members' Interest	[1]	Common Stock	Common Stock Class A Common Stock	Common Stock Class B-1 Common Stock	Common Stock Class B-2 Common Stock	Additional Paid-in Capital	(Accumulated Deficit) Retained Earnings	(Accumulated Deficit) Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Total Stockholders'/Members' Equity	Total Stockholders'/Members' Equity Cumulative Effect, Period of Adoption, Adjustment	Noncontrolling Interest
Beginning Balance at Feb. 02, 2019	$ 637,909		$ 1,347,622							$ (707,518)		$ (2,195)	$ 637,909
Accounting Standards Update [Extensible Enumeration]	us-gaap:AccountingStandardsUpdate201602Member
Consolidation of joint venture	$ (462)														$ (462)
Equity-based compensation expense (Note 13)	9,489		9,489										9,489
Partial settlement of member note	1,019		1,019										1,019
Net income (loss)	(103,984)									(95,873)			(95,873)		(8,111)
Contributions from noncontrolling interest	243														243
Foreign currency translation adjustment, net of tax	952											952	952
Unrealized loss on derivatives, net of tax	(9,088)											(9,088)	(9,088)
Losses on derivatives reclassified to income	2,058											2,058	2,058
Ending Balance at Feb. 01, 2020	561,061	$ 22,925	1,358,130							(780,466)	$ 22,925	(8,273)	569,391	$ 22,925	(8,330)
Equity-based compensation expense (Note 13)	12,915		9,757						$ 3,158				12,915
Repurchase of equity	(104)		(104)										(104)
Net income (loss)	(31,736)									(26,483)			(26,483)		(5,253)
Foreign currency translation adjustment, net of tax	(905)											(905)	(905)
Unrealized loss on derivatives, net of tax	(86)											(86)	(86)
Losses on derivatives reclassified to income	7,989											7,989	7,989
Contributions of Senior Notes(Note 9)	573,934								573,934				573,934
Conversion to Delaware corporation(Note 1)			$ (1,367,783)		$ 209				582,876	784,698
Conversion to Delaware corporation (Note1) (in shares)						171,224	37,791	37,791
Issuance of common stock	932,197				55				932,142				932,197
Issuance of common stock (in shares)						55,200
Ending Balance at Jan. 30, 2021	2,055,265				264				2,092,110	(22,251)		(1,275)	2,068,848		(13,583)
Ending Balance (in shares) at Jan. 30, 2021						226,424	37,791	37,791
Equity-based compensation expense (Note 13)	45,603								45,603				45,603
Net income (loss)	159,805									164,417			164,417		(4,612)
Foreign currency translation adjustment, net of tax	(963)											(963)	(963)
Unrealized loss on derivatives, net of tax	0
Losses on derivatives reclassified to income	0
Issuance of restricted stock awards (in shares)						55
Issuance of common stock	(3,891)				1				(3,892)				(3,891)
Issuance of common stock (in shares)						708
Ending Balance at Jan. 29, 2022	$ 2,255,819				$ 265				$ 2,133,821	$ 142,166		$ (2,238)	$ 2,274,014		$ (18,195)
Ending Balance (in shares) at Jan. 29, 2022						227,187	37,791	37,791

[1] Balances prior to the Company's conversion to a Delaware corporation were reclassified to additional paid-in capital to give effect to the organizational transactions described in Note 1